Sonoclear

Executive Summary

Sonoclear is a Norwegian medical device company dedicated to improving intraoperative ultrasound accuracy for neurosurgeons. Founded in 2016, the company has developed the SonoClear System, a sterile, advanced acoustic couplant engineered to enhance tumor border visualization during brain tumor resection. By providing clearer imaging, the system aims to help surgeons distinguish residual tumor from healthy brain tissue, thereby reducing the risk of neurological deficits. As a private company with no disclosed funding rounds or commercial products, Sonoclear is in the early stages of bringing its technology to market, focusing on regulatory approvals and clinical validation.

Upcoming Catalysts (preview)

• Q4 2026CE Mark Approval for SonoClear System65% success
• Q2 2027Completion of First-in-Human Clinical Study50% success
• H2 2026Strategic Partnership with a Neurosurgical Device Distributor45% success